LUMitimeless GHK-CU

GHK-Cu is a naturally occurring copper-binding tripeptide. Research literature on GHK-Cu — primarily in topical and in-vitro models — has explored its role in extracellular matrix remodeling and copper delivery to skin cells. LUMitimeless GHK-Cu is a compounded preparation prepared by a Philippine-licensed compounding pharmacy under your physician's order, for use within a physician-supervised regenerative protocol.

Each LUMitimeless GHK-Cu delivery ships discreetly and temperature-controlled:

• Lyophilized GHK-Cu vial — your prescribed dose
• Pharma-grade bacteriostatic (BAC) water — for reconstitution
• Insulin syringes — for subcutaneous injection
• 3cc syringe — for reconstitution
• Alcohol swabs
• Instruction card — step-by-step guide

Care Team support included via Viber — message us anytime if you have questions during preparation or injection.

LUMitimeless GHK-Cu is reconstituted from a lyophilized vial using the included bacteriostatic water, then administered as a subcutaneous injection at the dose and frequency your physician prescribes. Your physician confirms your protocol before your first supply is dispatched. Your Care Team checks in monthly via Viber.

Adults whose physician has assessed that a compounded copper peptide preparation may be appropriate as part of a regenerative or skin-supportive protocol. Injectable GHK-Cu is dispensed under physician order and is not a replacement for medical-grade dermatology where indicated. It is not equivalent to topical copper peptide skincare available over the counter.

Published human trial data for injectable GHK-Cu is sparse — most research has examined topical or in-vitro applications. Reported effects from clinical practice and limited studies include:

• Mild injection-site reactions (redness, swelling, tenderness)
• Transient erythema at injection site
• Mild hyperpigmentation at injection site (uncommon, typically resolves)

Systemic side effects are rare in available literature. Contraindications: patients with Wilson's disease (copper metabolism disorder), known copper hypersensitivity, or active malignancy should not use injectable GHK-Cu without specialist consultation — copper peptides have not been adequately studied in these populations. Not recommended during pregnancy or breastfeeding — no published safety data exists in these populations. Long-term safety data for injectable GHK-Cu is also limited. Tell your physician your full medical history, including any history of copper-related disorders or chelation therapy (D-penicillamine, trientine, high-dose zinc), before starting. Stop your dose and contact your physician immediately if you experience persistent injection-site reactions or any allergic response.

Medical emergency: if you experience difficulty breathing, swelling of face/lips/throat, severe chest pain, or fainting, call PH emergency services (117) or go to the nearest emergency room — do not wait for a Viber response.

LUMitimeless GHK-Cu is a compounded preparation prepared by a Philippine-licensed compounding pharmacy under a physician order specific to your treatment. It is not a Philippine FDA-registered branded product; it is a physician-ordered compounded preparation dispensed per DOH AO 2020-0001 (telehealth provider model). Injectable GHK-Cu differs from topical copper peptide skincare in delivery and dose. Use only under continuous physician supervision. Store refrigerated; do not freeze. Do not share your medication with anyone.